Influence in this corpus is measured by citation count, and the most-cited record is US6508860B1, an organosilicon-treated molecular sieve membrane patent with 226 citations, more than double the next most-cited filing. High citation counts favour older patents simply because they have had more time to be cited, so this reflects historical influence on the field rather than current market leadership. Anyone assessing freedom-to-operate should still review this filing closely, since later mixed matrix membrane work tends to build on it.

Filing activity peaked in 2017 at 31 records and had fallen to 2 in the most recent partial year, with a midpoint of 24 in 2022. Some of that recent decline is a publication-lag artefact, since patent applications typically take around eighteen months to publish, so the very last year or two will always look thinner than it eventually turns out to be. Even accounting for that lag, the broader trend from the 2017 peak through the 2022 midpoint points to a maturing rather than an accelerating field.

The United States receives the largest share of filings in this corpus at 125 records, followed by China at 64, the European Patent Office at 43, and the PCT international route at 40, with Canada and Japan further behind. This distribution suggests that companies in this space treat the US as the primary market to protect and enforce in. A freedom-to-operate review that skips US prosecution history would miss the bulk of the relevant claim landscape.

The dataset's search terms center on the permeability-selectivity tradeoff, plasticization resistance, mixed matrix membrane formulations, module design and long-term aging, and the IPC composition backs this up: every record touches B01D separation processes, with heavy secondary activity in condensation polymer chemistry and inorganic compound material science. In practice, this means most claims are directed either at improving the membrane material itself, often through filler incorporation, or at managing how that material behaves in a real module over time under plasticizing gas streams.

Filing density concentrates heavily on membrane material composition and mixed matrix filler chemistry, while module-level engineering details, long-term aging and conditioning protocols, and hollow-fiber packing density appear less densely claimed in this corpus. That does not mean these areas are unclaimed, but the relative filing density is lower, which is where a well-drafted first claim has more room to stand apart from existing prior art. Companies scoping new R&D should verify current filing activity in these branches before assuming the space is open.